Neoleukin Therapeutics Inc (NLTX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 115.95M | 98.46M | 94.01M | 89.59M | 222.57M | 195.35M | 179.82M | 164.12M |
流動資産合計 | 99.13M | 85.64M | 83.78M | 79.89M | 200.35M | 174.14M | 159.15M | 143.65M |
現金および同等物 | 37.89M | 35.49M | 31.11M | 25.23M | 148.21M | 150.14M | 111.03M | 66.63M |
非流動資産合計 | 22.98M | 12.82M | 10.23M | 9.69M | 39.3M | 37.6M | 36.64M | 36.46M |
負債合計 | 21.62M | 17.1M | 14.43M | 14.35M | 36.55M | 24.57M | 24.81M | 26.71M |
流動負債合計 | 11.06M | 7.16M | 4.88M | 5.21M | 22.97M | 11.82M | 13.07M | 15.8M |
非流動負債合計 | 10.79M | 9.95M | 9.56M | 9.14M | 13.64M | 12.81M | 11.79M | 10.95M |
普通株 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
留保所得 | -451.06M | -465.26M | -467.34M | -471.87M | -187.15M | -204.08M | -222.57M | -242.78M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 154.38M | 110.33M | 77.62M | 147.02M | 210.52M | 163.26M | 115.95M | 222.57M |
流動資産合計 | 103.49M | 108.83M | 77.17M | 143.6M | 194.52M | 143.99M | 99.13M | 200.35M |
現金および同等物 | 32.3M | 52.03M | 76.93M | 143.09M | 192.56M | 142.47M | 37.89M | 148.21M |
非流動資産合計 | 144.66M | 98.89M | 72.67M | 141.69M | 191.22M | 142.86M | 94.33M | 186.02M |
負債合計 | 9.72M | 11.44M | 4.95M | 5.34M | 19.3M | 20.4M | 21.62M | 36.55M |
流動負債合計 | 9.52M | 10.97M | 4.63M | 4.74M | 7.89M | 8.64M | 11.06M | 22.97M |
非流動負債合計 | 244k | 487k | 325k | 739k | 11.52M | 11.83M | 10.79M | 13.64M |
総資本 | 144.66M | 98.89M | 72.67M | 141.69M | 191.22M | 142.86M | 94.33M | 186.02M |
普通株 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
留保所得 | -148.28M | -198.5M | -230.09M | -299.53M | -332.81M | -393.5M | -451.06M | -187.15M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約